Abstract
Abstract In this chapter, Mie Højris Dahl explores how sectoral differences and firm size impact the way that multinational enterprises articulate their global wealth chains. Dahl contrasts three beer and three pharmaceutical firms to assess how firm size informs wealth chain asset strategy. The contrast is between a simply commodity-based product, beer, and a product with high levels of intellectual property content, pharmaceuticals. Drawing on Orbis data, Dahl maps corporate structures to find where value chains and wealth chains are present, differentiating their function and jurisdictional location. Dahl finds that firm size and the extent of internationalization inform wealth chain use, especially modular and captive forms, with beer firms using wealth chains as much as pharmaceutical firms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
